Chair of the IAPRD 2018 Scientific Program Executive Committee, Hubert Fernandez (Cleveland Clinic, Cleveland, OH, US), discusses identification of patients with Parkinson's disease (PD) at risk of cognitive decline, the advantages of levodopa-carbidopa intestinal gel in advanced PD, recent exciting advances in PD therapy, as well as strengths and highlights of this year's meeting.
1. How can we best identify patients with Parkinson's disease (PD) at risk of cognitive decline? (0:14)
2. What are the advantages of levodopa-carbidopa intestinal gel in advanced PD? (3:00)
1. What do you consider the most exciting advances in PD therapy in recent years? (0:14)
2. What do consider are the greatest strengths of the IAPRD meeting? (3:57)
3. What do you expect to be the highlights of IAPRD 2018? (5:08)
Filmed at the XXII World Congress on Parkinson's Diseases and Related Disorders (IAPRD), Lyon, France, August 2018.
Speaker disclosure (over the past 12 months).
Grants/Research Support: Dr. Fernandez has received research support from Abbvie, Acadia, Teva, Biotie/Acorda Therapeutics, Civitas, Kyowa/Prostrakan, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Rhythm, Synosia, but has no owner interest in any pharmaceutical company.
Honoraria: Dr. Fernandez has received honoraria from Prime Education Inc. International Parkinson and Movement Disorders Society, Carling Communications, Medscape, as a speaker in CME events. Dr. Fernandez has received honoraria from AbbVie, Biogen, GE Health Care, Inventiv, Kyowa Hakko Kirin, Lundbeck, Medscape, Merz Pharmaceuticals, Voyager, Sunovion, and Pfizer Pharmaceuticals, as a consultant.
Royalty: Dr. Fernandez has received royalty payments from Demos Publishing for serving as a book author/editor.
Contractual Services: The Cleveland Clinic has a contract with Teva for Dr. Fernandez' role as a Co-Principal Investigator in SD-809 Tardive Dyskinesia global studies. Dr. Fernandez also serves as a member of the publication committee for Acorda Pharmaceuticals but does not receive any personal compensation for these.
Other: Dr. Fernandez has received a stipend from International Parkinson and Movement Disorders Society for serving as Medical Editor of the MDS Web Site.